SPAG9 was first identified from a human testis cDNA library as a member of the CT (cancer testis) antigen family in 1998 and was later found to be involved in the regulation of a variety of tumor invasion and migration factors and viral replication via MAPK signaling (27, 29, 30). Here, SPAG9 is linked to cancer.